HomeStock ScreenerBiogen PharmachemShareholding Pattern

Biogen Pharmachem Shareholding Pattern

As of Mar 2026, Biogen Pharmachem (BIOGEN) promoter holding 0.00%, FII 0.00%, DII 0.00%, public 56.92%, total shareholders 289,155. Review BIOGEN price earnings ratio to evaluate earnings-based valuation against sector peers.

Promoter Holding 0.00%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 56.92%
Total Shareholders 289,155
As of Mar 2026

BIOGEN Recent Shareholding Changes — Promoter, FII & DII

Biogen Pharmachem promoter, FII and DII holding change from Dec 2025 to Mar 2026. Check BIOGEN market value to track the company's total market size over time.

Promoter Holding Change
Dec 2025 to Mar 2026
No Change
FII Holding Change
Dec 2025 to Mar 2026
No Change
DII Holding Change
Dec 2025 to Mar 2026
No Change
Public Holding Change
Dec 2025 to Mar 2026
+1.49%

Biogen Pharmachem Quarterly Shareholding Trend — Promoter, FII, DII & Public

BIOGEN promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see Biogen Pharmachem share price screener.

Promoter
FII
DII
Public
Government

BIOGEN Shareholding Pattern Data — Quarterly History

Biogen Pharmachem quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 0.00% 0.00% 0.00% 0.00% 56.92% 43.07% 99.99% 289,155
Dec 2025 0.00% 0.00% 0.00% 0.00% 55.43% 44.56% 99.99% 289,987
Sept 2025 0.00% 0.00% 0.00% 0.00% 55.38% 44.62% 100.00% 293,327
Jun 2025 0.00% 0.00% 0.00% 0.00% 55.33% 44.67% 100.00% 303,922
Mar 2025 0.00% 0.00% 0.00% 0.00% 76.46% 23.54% 100.00% 302,362
Dec 2024 0.00% 0.00% 0.00% 0.00% 76.46% 23.54% 100.00% 303,780
Sept 2024 0.00% 0.00% 0.00% 0.00% 76.29% 23.71% 100.00% 280,600
Jun 2024 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,795
Mar 2024 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,757
Dec 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,832
Sept 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,826
Jun 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,822
Mar 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,828
Dec 2022 0.00% 0.00% 0.00% 0.00% 76.88% 23.12% 100.00% 190,531
Sept 2022 0.00% 0.00% 0.00% 0.00% 76.69% 23.30% 99.99% 184,269
Jun 2022 0.00% 0.00% 0.00% 0.00% 76.63% 23.37% 100.00% 181,742
Mar 2022 0.00% 0.00% 0.00% 0.00% 76.42% 23.58% 100.00% 170,033
Dec 2021 0.00% 0.00% 0.00% 0.00% 73.58% 26.42% 100.00% 99,881
Sept 2021 0.00% 0.00% 0.00% 0.00% 72.45% 27.55% 100.00% 83,112
Jun 2021 0.00% 0.00% 0.00% 0.00% 53.85% 46.15% 100.00% 31,589
Mar 2021 0.00% 0.00% 0.00% 0.00% 17.86% 82.13% 99.99% 9,405
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 0.00% 0.00% 0.00% 0.00% 56.92% 43.07% 99.99% 289,155
Dec 2025 0.00% 0.00% 0.00% 0.00% 55.43% 44.56% 99.99% 289,987
Sept 2025 0.00% 0.00% 0.00% 0.00% 55.38% 44.62% 100.00% 293,327
Jun 2025 0.00% 0.00% 0.00% 0.00% 55.33% 44.67% 100.00% 303,922
Mar 2025 0.00% 0.00% 0.00% 0.00% 76.46% 23.54% 100.00% 302,362
Dec 2024 0.00% 0.00% 0.00% 0.00% 76.46% 23.54% 100.00% 303,780
Sept 2024 0.00% 0.00% 0.00% 0.00% 76.29% 23.71% 100.00% 280,600
Jun 2024 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,795
Mar 2024 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,757
Dec 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,832
Sept 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,826
Jun 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,822
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 0.00% 0.00% 0.00% 0.00% 56.92% 43.07% 99.99% 289,155
Dec 2025 0.00% 0.00% 0.00% 0.00% 55.43% 44.56% 99.99% 289,987
Dec 2024 0.00% 0.00% 0.00% 0.00% 76.46% 23.54% 100.00% 303,780
Dec 2023 0.00% 0.00% 0.00% 0.00% 76.85% 23.15% 100.00% 197,832
Dec 2022 0.00% 0.00% 0.00% 0.00% 76.88% 23.12% 100.00% 190,531
Dec 2021 0.00% 0.00% 0.00% 0.00% 73.58% 26.42% 100.00% 99,881